Adenosine nucleotides in rat bone measured by ion-pair reversed-phase high-performance liquid chromatography: effect of hemorrhagic shock, with and without retransfusion of blood

被引:9
作者
Manoharan, M
Schwille, RM
Schwille, PO
机构
[1] Univ Erlangen Nurnberg, Dept Surg, Div Expt Surg, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Surg, Endocrine Res Lab, D-91054 Erlangen, Germany
来源
JOURNAL OF CHROMATOGRAPHY B | 2001年 / 761卷 / 02期
关键词
hemorrhagic shock; blood retransfusion; adenosine nucleotides; nucleotides;
D O I
10.1016/S0378-4347(01)00307-3
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The measurement of bone adenosine nucleotides (ATP, ADP, AMP) using a simple HPLC procedure is described for rat tibia; the response to hemorrhagic shock with and without blood retransfusion is also described. With respect to the measurement of nucleotides, a number of validation criteria are met. In the anesthetized intact rat (Normal) there was a declining gradient of the three nucleotides, expressed as nmol per dry matter, from proximal over middle to distal diaphysis, with the mean ratio ATP/ADP (0.21, 0.20, 0.20) and the mean energy charge (0.34, 0.31, 0.30) being low. Irrespective of the anatomic site, hemorrhagic shock of 30-min duration evoked a further decrease versus Normal of ATP, ATP/ADP and energy charge. Blood retransfusion after shock kept nucleotides and other variables in the proximal and distal, but not the middle, diaphysis within normal limits. It was concluded that: (i) bone nucleotides are reliably measurable by HPLC, allowing the described method to be recommended for wider use in bone research and related areas; (ii) in contrast to more parenchymatous tissues, low ATP, ATP/ADP and energy charge may be characteristic for long bones, pointing towards different energy metabolism; and (iii) bone is a "shock organ", reflecting blood hypoperfusion, O-2 deficiency and decreased ATP in this situation. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:159 / 166
页数:8
相关论文
共 21 条
[21]  
YAMAGUCHI M, 1990, CHEM PHARM BULL, V38, P1660